The healthcare industry is a complex and rigid space where change is often rejected. Any evolution in this sector not only signifies business decisions but also influences the overall quality and accessibility of patient care.
In this episode of the M&A Science Podcast, Roy Schoenberg, President & Co-CEO at Amwell, delves into the intricacies of navigating M&A in the healthcare industry.
This episode is sponsored by the M&A Science Academy, DealRoom, and FirmRoom.
To join our growing online community of M&A practitioners, visit www.mascience.com/academy.
Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at www.dealroom.net.
FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to www.firmroom.com.
04:26 Evolving from a medical background to M&A
07:27 What makes the healthcare space distinct
09:36 What drove Amwell to do acquisitions
13:03 Shaping the acquisition strategy
16:59 Amwell’s first acquisition
22:29 Integrating the new company
24:50 Retaining key people
28:33 First acquisition lessons learned
31:03 Dealing with transaction surprises
34:03 Approaching deals as one of the main principal
38:01 Deal sourcing
39:49 Managing relationships with the counterparty
41:30 Communication during diligence
43:14 Craziest thing in M&A